Analyst Price Targets — HUMA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| December 1, 2025 11:35 am | Swayampakula Ramakanth | H.C. Wainwright | $3.00 | $1.35 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on Humacyte (HUMA) |
| October 13, 2025 11:19 am | — | UBS | $6.00 | $1.68 | TheFly | Humacyte price target lowered to $6 from $7 at BTIG |
| August 27, 2025 8:37 am | Matt Miksic | Barclays | $3.50 | $1.47 | TheFly | Humacyte initiated with an Overweight at Barclays |
| October 18, 2024 7:51 am | Matt O'Brien | Piper Sandler | $6.00 | $4.86 | StreetInsider | Piper Sandler Reiterates Neutral Rating on Humacyte (HUMA) |
| October 18, 2024 5:41 am | Ryan Zimmerman | BTIG | $10.00 | $4.86 | StreetInsider | BTIG Reiterates Buy Rating on Humacyte (HUMA) |
| December 20, 2022 10:49 am | Cowen Cowen | Cowen & Co. | $5.00 | $2.21 | Pulse 2.0 | Humacyte (HUMA) Stock Gets A $5 Price Target |
| May 15, 2022 9:11 pm | Matt O'Brien | Piper Sandler | $4.00 | $5.37 | TheFly | Humacyte downgraded to Underweight from Overweight at Piper Sandler |
Latest News for HUMA
Humacyte, Inc. (HUMA) reached $0.68 at the closing of the latest trading day, reflecting a -7.13% change compared to its last close.
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Humacyte, Inc. (NasdaqGS: HUMA) (“Humacyte” or the “Company”). On August 9, 2024, the company announced that the Food and Drug Administration (“FDA”) “will require additional time to complete…
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
In the latest trading session, Humacyte, Inc. (HUMA) closed at $0.61, marking a -6.63% move from the previous day.
The latest trading day saw Humacyte, Inc. (HUMA) settling at $0.59, representing a -2.44% change from its previous close.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
No House trades found for HUMA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.